ArticleAnti-cancer drugs2016

Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.

Kazuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.